Entheon Biomedical (XCNQ:ENBI) Shares Buyback Ratio % : 0.00 (As of Jun. 05, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Entheon Biomedical's current shares buyback ratio was 0.00%.

Entheon Biomedical Shares Buyback Ratio % Historical Data

The historical data trend for Entheon Biomedical's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Shares Buyback Ratio % Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-49.56

-879.08

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-	-	-

Entheon Biomedical Shares Buyback Ratio % Calculation

Entheon Biomedical's Shares Buyback Ratio for the fiscal year that ended in Nov. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Nov. 2022 )	-	Shares Outstanding (EOP) (A: Nov. 2023 ))	/	Shares Outstanding (EOP) (A: Nov. 2022 )
	=	(5.90893	-	5.90893)	/	5.90893
	=	0.00%

Entheon Biomedical's Shares Buyback Ratio for the quarter that ended in Feb. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Nov. 2023 )	-	Shares Outstanding (EOP) (A: Feb. 2024 ))	/	Shares Outstanding (EOP) (A: Nov. 2023 )
	=	(5.90893	-	5.90893)	/	5.90893
	=	0.00%

Entheon Biomedical Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Executives

Brian Jahns

Senior Officer

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines